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Highlights 1 
 We clarify the equivalence of body composition analysis from computed 2 
tomography (CT) images using two different software packages.  3 
 Analysis was performed using SliceOmatic and OsiriX packages on 50 patients 4 
who had undergone tri-phasic scans. 5 
 Body composition measures were significantly different between the two 6 
software packages, but the clinical significance of these is doubtful. 7 
 However, we recommend that for serial body composition analysis and for 8 
comparative purposes, the software package employed should be consistent.  9 
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Abstract 57 
Objectives: Body composition analysis from computed tomography (CT) imaging has 58 
become widespread. However, the methodology used is far from established. Two main 59 
software packages are in common usage for body composition analysis, with results used 60 
interchangeably. However, the equivalence of these has not been well established. The aim 61 
of this study was to compare the results of body composition analysis performed using the 62 
two software packages to assess their equivalence. 63 
Methods: Tri-phasic abdominal CT scans from 50 patients were analysed for a range of body 64 
composition measures at the third vertebral level using OsiriX (v7.5.1, Pixmeo, Switzerland) 65 
and SliceOmatic (v5.0, TomoVision, Montreal, Canada) software packages. Measures 66 
analysed were skeletal muscle index (SMI), fat mass (FM), fat free mass (FFM) and mean 67 
skeletal muscle Hounsfield Units (SMHU). 68 
Results: The overall mean SMI calculated using the two software packages was significantly 69 
different (SliceOmatic 51.33 vs. OsiriX 53.77, p<0.0001), and this difference remained 70 
significant for non-contrast and arterial scans. When FM and FFM were considered, again 71 
the results were significantly different (SliceOmatic 33.7kg vs. OsiriX 33.1kg, p<0.0001; 72 
SliceOmatic 52.1kg vs. OsiriX 54.2kg, p<0.0001, respectively), and this difference remained 73 
for all phases of CT. Finally, when mean SMHU was analysed, this was also significantly 74 
different (SliceOmatic 32.7 HU vs. OsiriX 33.1 HU, p=0.046). 75 
Conclusions: All four body composition measures were statistically significantly different by 76 
the software package used for analysis, however the clinical significance of these differences 77 
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is doubtful. Nevertheless, the same software package should be utilised if serial 78 
measurements are being performed. 79 
 80 
Key words: computed tomography; body composition; sarcopenia; myosteatosis; OsiriX; 81 
SliceOMatic  82 
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Introduction 84 
Computed tomography (CT) analysis of body composition to measure fat mass (FM) and fat 85 
free mass (FFM), calculate skeletal muscle index (SMI), and diagnose sarcopenia and 86 
myosteatosis has become increasingly common, with literature now linking sarcopenia and 87 
myosteatosis with reduced overall survival [1, 2], decreased tolerance to chemotherapy [3, 88 
4] and increased complications [5, 6] following surgery in patients presenting with various 89 
types of malignancy.  90 
However, the methodology for calculating body composition from CT images is variable 91 
between studies, from the nature of the CT scan used including the vertebral level, to the 92 
use of contrast medium, to the software used to perform the analysis. The impact of the use 93 
of contrast medium in CT scanning in body composition analysis has previously been 94 
recognised to have a significant effect upon results, especially the diagnosis of myosteatosis 95 
[7, 8]. Despite these inconsistencies in analysis, the results of these studies are used 96 
interchangeably, with the definition of neither sarcopenia or myosteatosis stipulating any 97 
conditions about how these derived values are calculated. 98 
There are currently two software packages used commonly to analyse body composition 99 
from CT scans: SliceOmatic (TomoVision, Montreal, Canada) and OsiriX (Pixmeo, 100 
Switzerland), the results of which are also used interchangeably. One study in patients with 101 
rectal cancer [9] has suggested that SliceOmatic, ImageJ (National Institutes of Health, 102 
Bethesda, MD, USA), FatSeg [Biomedical Imaging Group Rotterdam of Erasmus MC, 103 
Rotterdam, The Netherlands, using MeVisLab (Mevis Medical Solutions, Bremen, Germany)] 104 
and OsiriX analysis provide excellent levels of agreement. However, this study [9] did not 105 
consider mean skeletal muscle Hounsfield Unit as a surrogate for myosteatosis. The aim of 106 
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the present study was to compare the SliceOmatic and OsiriX software packages and 107 
determine if there was a difference in calculated measures of body composition, namely 108 
SMI, FM, FFM and mean skeletal muscle Hounsfield units (SMHU), using CT scan images.  109 
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Methods 110 
In a single centre retrospective study, CT scans from 50 patients who underwent triple 111 
phase abdominal scans (non-contrast, arterial and portovenous phases) between April 2014 112 
and September 2015 were analysed using two different software packages; SliceOmatic v5.0 113 
and OsiriX v7.5.1. The patients were initially identified retrospectively from the 114 
Computerised Radiology Information System (CRIS v 2.09, HSS, Healthcare Systems, 115 
Mansfield, UK). The underlying pathology necessitating the CT scan was variable, and 116 
included trauma, suspected intra-abdominal or gastrointestinal bleeding, pancreatic or 117 
hepatic pathology and renal lesions. Three axial slices were selected from each tri-phasic 118 
abdominal CT scan (total analysed slices in the study = 50 x 3 = 150 slices). Each slice was 119 
anatomically localised using coronal and sagittal multi-planar reformats (MPRs) to ensure it 120 
specifically lies at the third lumbar vertebra (L3). Slices were analysed as Digital Imaging and 121 
Communication in Medicine (DICOM) images obtained from the Picture Archiving and 122 
Communication System (PACS). Electronic patient data were collated for patient 123 
demographics, including height and weight data from within one month of the date of the 124 
CT scan.  125 
Scan Acquisition 126 
During the study period there were two CT scanners in use at Nottingham University 127 
Hospitals NHS Trust were the study was conducted; (1) Ingenuity 128; Phillips Healthcare, 128 
Best, The Netherlands and (2) Optima CT660, GE Healthcare, WI, USA and these were 129 
calibrated once per week to ensure that quality assurance testing was met for the 130 
Hounsfield Unit (HU) density of air (HU=-1000) and water (HU=zero). Arterial and 131 
portovenous phase scans were obtained using intravenous administration of contrast 132 
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medium (100 ml fixed dose of Iopamidol, Niopam 300, Bracco, Buckinghamshire, UK). The 133 
timings of different phase scans were standardised, firstly with an unenhanced scan, then 134 
the arterial phase performed at 10-20 seconds and finally the portovenous scan at 65 135 
seconds.  136 
Body Composition Analysis  137 
The three phases of CT scan slice on each individual patient were analysed by a single 138 
observer, our group having previously established high rates of inter-observer reliability 139 
(SMI r2=0.975, p<0.0001; mean SMHU r2=0.965, p<0.0001) in the analysis of body 140 
composition variables using the techniques adopted in this study [7]. The software 141 
packages, SliceOmatic and OsiriX were each used to calculate the cross-sectional area of 142 
skeletal muscle, visceral and subcutaneous/intramuscular adipose tissue. The different 143 
tissue types were identified by their differing radiodensities; skeletal muscle of -29 to +150 144 
HU, visceral adipose of -150 to -50 HU and subcutaneous/intramuscular adipose of -190 to -145 
30 HU. The mean SMHU density was also recorded for all scans analysed.  146 
Previously described regression equations for the calculation of whole body FM and FFM 147 
from a single cross-sectional CT slice were used [10]: 148 
Total body fat mass (FM) (kg) = 0.042 x [total adipose tissue area at L3(cm2)] + 11.2 149 
Total body fat free mass (kg) = 0.3 x [total skeletal muscle area at L3 (cm2)] + 6.06 150 
The cross-sectional area of skeletal muscle was also transformed into the skeletal muscle 151 
index (SMI) by modifying it by patient height. 152 
 153 
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Statistical Analysis 154 
Statistical analysis was performed using SPSS (v22.0, IBM, SMSS Statistics, Armonk, NY, USA) 155 
and GraphPad Prism v6.0 (GraphPad, La Jolla, CA, USA). FM, FFM, SMI and mean SMHU 156 
density values, with data checked for normality using the D’Agostino-Pearson normality 157 
test. Data were compared between different software packages using the Student t-paired 158 
test when normality was confirmed, and the Wilcoxon matched-pairs signed rank test when 159 
the data were not distributed normally. Pearson’s coefficient of correlation was used to 160 
compare the body composition values calculated from the two different software packages 161 
and Bland Altman plots utilised to reveal any systematic error between the analyses. All 162 
analyses were performed using two tailed testing with a significance level set at p<0.05.   163 
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Results 164 
Of the 50 patients included during the study period of April 2014 to September 2015 there 165 
were 33 males and 17 females, with a mean body mass index (BMI) of 30.4 (SD 4.0) kg/m2.  166 
Skeletal Muscle Index (SMI) 167 
Analysis of body composition by OsiriX gave a significantly greater value for SMI than scans 168 
analysed using SliceOmatic (53.8 cm2/m2 vs. 51.3 cm2/m2, p<0.0001) on Wilcoxon matched-169 
pairs signed rank test, performed due the D’Agostino-Pearson test demonstrating a lack of 170 
normality in the data from OsiriX analysis (K2=7.831, p=0.012). This difference remained 171 
between scans analysed in non-contrast and arterial phase, however there was no 172 
difference in scans analysed in the portovenous phase (Table 1).  173 
There was a significant positive correlation in SMI between analysis conducted using OsiriX 174 
and SliceOmatic software (r=0.965, p<0.0001) and evidence of a positive systematic bias on 175 
Bland Altman testing (average bias = 2.432) (Figure 1). 176 
Fat Mass (FM) 177 
FM calculated by OsiriX was significantly lower than that calculated by SliceOmatic (33.1 kg 178 
vs. 33.7 kg, p<0.0001) as calculated by the student t-paired test as the data were 179 
demonstrated to be normally distributed, and this difference was seen when all individual 180 
phase data were analysed (Table 1).  181 
The correlation between FM analysis using OsiriX and SliceOmatic was significant (r=0.997, 182 
p<0.0001) and Bland Altman testing revealed no evidence of a systematic bias (average bias 183 
= -0.680) (Figure 2). 184 
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Fat Free Mass (FFM) 185 
Analysis of FFM using the two software packages demonstrated significantly greater values 186 
with OsiriX analysis versus SliceOmatic (54.2 kg vs. 52.1 kg, p<0.0001) as calculated by the 187 
student t-paired test as the data were demonstrated to be normally distributed. This finding 188 
remained consistent in slices analysed in non-contrast, arterial and portovenous phases 189 
(Table 1). 190 
There was a significant positive correlation between analysis of FFM performed using OsiriX 191 
versus SliceOmatic software packages (r=0.977, p<0.0001) and there was evidence of a 192 
systematic bias on Bland Altman testing (average bias = 2.16) (Figure 3). 193 
Mean Skeletal Muscle Hounsfield Units (SMHU) 194 
The mean SMHU density was overall significantly higher when analysed using OsiriX versus 195 
SliceOmatic software (33.1 vs. 32.7 HU, p=0.046) as calculated by the student t-paired test 196 
as the data were demonstrated to be normally distributed. However, when the individual 197 
phases of CT scan were compared, there were no significant differences between OsiriX and 198 
SliceOmatic (Table 1).  199 
There was a significant positive correlation in the mean SMHU between the two software 200 
packages (r=0.976, p<0.0001) and no evidence of any systematic bias (average bias = 0.360) 201 
(Figure 4).  202 
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Discussion 203 
This study provides evidence of the relative clinical equivalence of analysis of body 204 
composition measures analysed by two different software packages, namely OsiriX and 205 
SliceOmatic. However, statistically significantly greater SMI, FFM and mean SMHU values 206 
and significantly lower FFM were demonstrated when the analyses were performed with 207 
OsiriX compared with SliceOmatic. There was significant positive correlation for all measures 208 
when the two software packages were compared, although Bland Altman testing revealed 209 
evidence of a significant systematic bias when analysing SMI and FFM. The results of the 210 
present study are similar to those of the previously published comparison of OsiriX, 211 
SliceOmatic, ImageJ and FatSeg [9] which found that body composition in terms of cross-212 
sectional muscle area, visceral adipose tissue area and subcutaneous adipose tissue area 213 
had excellent levels of agreement, suggesting that the results of analysis using the different 214 
software packages could be used interchangeably. However, this study suggested evidence 215 
of a systematic bias in the analysis of SMI and FFM which should be considered when 216 
comparing results of body composition analysis performed using different software 217 
packages. That study [9], however, did not include myosteatosis, as calculated by the mean 218 
SMHU value, which is becoming increasingly utilised in body composition analysis. In 219 
addition, the present study considered the different phases of abdominal CT (non-contrast, 220 
arterial and portovenous) which was not considered by the previous literature; indeed no 221 
statement is made regarding the phase of CT scan considered by the previous study [9].  222 
Whilst the results of the present study demonstrate statistically significant differences in 223 
body composition variables by software package used for analysis, the clinical significance of 224 
several of these outcomes is doubtful. The mean SMHU was different by just 0.4 HU, much 225 
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less than the difference in SMHU between different phases of CT scan (in OsiriX analysis a 226 
difference of 5.1 HU was seen between non-contrast and portovenous scans and 5.3 HU in 227 
SliceOmatic analysis). This discrepancy in radiodensity of skeletal muscle has been 228 
documented previously [7] and its clinical relevance questioned. Therefore, with such a 229 
small difference this is very unlikely to impact significantly upon the diagnosis of 230 
myosteatosis. Similarly, the difference between software packages was minimal in FM 231 
analysis, with an overall difference of 0.7 kg, which represents just 1.8% of the overall mass 232 
from OsiriX analysis. The difference was more pronounced in SMI and FFM analysis, with a 233 
difference of 2.5 cm2/m2 (4.6%) and 2.1 kg (3.9%) respectively, which are more likely to 234 
represent a clinically relevant difference. This difference in body composition variables has 235 
not been demonstrated previously, and the results of body composition analysis using OsiriX 236 
and SliceOmatic software packages are used interchangeably within the literature.  237 
This study was conducted retrospectively. However, all scans were performed on individual 238 
patients at the same time, so whilst the hydration status was not known, it would be 239 
consistent for all scans and, therefore, would not impact upon these results. Height and 240 
weight data were not always available from the date of the scan which may render the 241 
calculation of body composition measures less accurate.  242 
Further work on body composition analysis is necessary in order to standardise the 243 
methodology used to calculate clinical body composition outcomes including the presence 244 
of sarcopenia and myosteatosis. This should include muscle biopsy samples of the rectus 245 
abdominis at the L3 vertebral level to correlate radiological and histological analysis of 246 
skeletal muscle. 247 
 248 
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This is the first study to investigate the analysis of body composition variables including 249 
myosteatosis by software package of analysis, and has demonstrated statistically significant 250 
differences in values in all outcomes. Although some statistically significant differences were 251 
demonstrated between the two software packages, these are unlikely to be clinically 252 
relevant. However, given the demonstrable differences in body composition measures, it is 253 
suggested that the two packages should not be used interchangeably for clinical or research 254 
purposes. 255 
 256 
 257 
 258 
 259 
 260 
 261 
 262 
 263 
  264 
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Legends for figures 320 
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Figure 1 – Correlation between mean skeletal muscle index (SMI) calculated using OsiriX and 322 
SliceOmatic software packages and Bland Altman plots to assess for systematic bias. 323 
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Figure 2 – Correlation between fat mass (FM) calculated using OsiriX and SliceOmatic 325 
software packages and Bland Altman plots to assess for systematic bias. 326 
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Figure 3 – Correlation between fat free mass (FFM) calculated using OsiriX and SliceOmatic 328 
software packages and Bland Altman plots to assess for systematic bias. 329 
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Figure 4 – Correlation between mean skeletal muscle Hounsfield Units (SMHU) calculated 331 
using OsiriX and SliceOmatic software packages and Bland Altman plots to assess for 332 
systematic bias. 333 
 334 
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Table 1 – Comparison of body composition measures calculated by OsiriX versus SliceOmatic 336 
software packages in non-contrast, arterial and portovenous phase scans. 337 
 338 
  339 
 340 
 
 
Non-Contrast Phase 
Scan 
Arterial Phase Scan Portovenous Phase 
Scan 
Skeletal Muscle Index (cm2/m2)  standard deviation 
SliceOmatic 51.0  10.1 51.4  10.1 51.6  9.9 
OsiriX 53.3  10.4 53.6  11.1 54.4  10.7 
Mean difference 
between modalities 
-2.3  2.2 -2.2  3.3 -2.7  3.0 
P Value <0.0001 <0.0001 0.189 
Fat Mass (kg) 
SliceOmatic 34.1  9.1 33.7  8.9 33.5  9.0 
OsiriX 33.4  9.0 33.0  8.7 32.8  9.0 
Mean difference 
between modalities 
0.7  0.6 0.7  0.8 0.7  0.5 
P value <0.0001 <0.0001 <0.0001 
Fat Free Mass (kg)    
SliceOmatic 51.8  11.3 52.1  11.3 52.3  11.3 
OsiriX 53.9  11.7 54.1  12.1 54.8  11.9 
Mean difference 
between modalities 
-2.1  2.0 -2.0  2.9 -2.4  2.7 
P value <0.0001 <0.0001 <0.0001 
Mean Skeletal Muscle Hounsfield Units (HU) 
SliceOmatic 30.1  9.3 33.0  9.9 35.4  10.2 
OsiriX 30.6  8.6 32.7  9.4 35.7  10.0 
Mean difference 
between modalities 
-0.5  2.2 0.3  2.1 -0.2  2.4 
P value 0.120 0.213 0.450 
